Oesophageal Manometry Probe Market Size, Share, Trends & Forecast

The Oesophageal Manometry Probe Market is expanding as healthcare providers seek more accurate ways to diagnose disorders affecting esophageal movement and pressure. According to WiseGuyReports, the market was valued at approximately USD 300 million in 2024 and 2025 and is projected to reach USD 500 million by 2035, growing at a 5.9% CAGR from 2026 to 2035.

Technological development is playing an important role in market expansion. The industry includes solid-state probes, water-perfused probes, and high-resolution manometry probes, with high-resolution systems gaining attention because they can provide detailed pressure mapping of the esophagus. Improved software integration and clearer graphical interpretation are also helping clinicians evaluate complex motility disorders more efficiently.

The application landscape includes gastroesophageal reflux disease, achalasia, dysphagia, and esophageal motility disorders. Achalasia represented a market value of about USD 60 million in 2024 and is projected to reach approximately USD 100 million by 2035, while GERD remains an important source of demand because of its widespread prevalence.

Hospitals represent an important end-use environment, supported by their access to specialized gastroenterology services and diagnostic equipment. Ambulatory surgical centers and diagnostic laboratories are also contributing to demand as healthcare systems increasingly use outpatient and specialized diagnostic settings. Regionally, North America leads the market, while Asia Pacific is expected to experience significant growth as healthcare infrastructure, awareness, and investment improve.

Looking ahead, opportunities are emerging around more comfortable probes, single-use designs, artificial intelligence, and advanced data analytics. AI-assisted interpretation could help clinicians analyze complex manometry results, while connected systems may support better patient monitoring and follow-up. Increasing demand for minimally invasive diagnostics and the growing prevalence of gastrointestinal disorders should continue creating opportunities for manufacturers and healthcare technology providers.